immunotherapy

Advaxis And Inovio Race For First Cervical Cancer Immunotherapy
Seeking Alpha
Thu, 01/23/14 - 09:48 am
Advaxis
Inovio
cervical cancer
immunotherapy
ADXS-HPV
VGX-3100
Amazon's Jeff Bezos bets some of his personal cash on Juno's immunotherapy tech
Fierce Biotech
Tue, 01/14/14 - 10:00 am
Amazon
Jeff Bezos
Juno Therapeutics
immunotherapy
OncoSec Medical Poised for Exciting 2014
Wall St Cheat Sheet
Mon, 12/30/13 - 11:39 am
OncoSec Medical
melanoma
skin cancer
immunotherapy
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
Fri, 12/27/13 - 01:08 pm
cancer
Roche
Infinity Pharmaceuticals
Inovio
Immunogen
Gilead Sciences
immunotherapy
antibody-drug conjugate
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Fri, 12/20/13 - 11:49 am
Inovio
Pharma CEOs
PDL-1
immunotherapy
Joseph Kim
Bristol-Myers Squibb
Roche
Dendreon
GSK
ImmunoCellular Therapeutics
Merck
Northwest Biotherapeutics
Merck’s Investigational Grass Sublingual Allergy Immunotherapy Tablet Significantly Reduced Allergy Symptoms and Need for Symptom-Relief Medication in Adults and Children in Pivotal Phase III Study
Yahoo/BusinessWire
Sun, 11/10/13 - 01:13 pm
Merck
immunotherapy
MK-7243
allergies
MorphoSys Plans to Raise Spending on Immunotherapy Treatments
Bloomberg
Thu, 08/1/13 - 08:42 am
MorphoSys
immunotherapy
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
Minyanville
Tue, 06/18/13 - 11:53 am
immunotherapy
Celldex
OncoSec
ImmunoCellular Therapeutics
Northwest Biotherapeutics
Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?
Seeking Alpha
Mon, 06/10/13 - 12:23 pm
immunotherapy
NewLink Genetics
Roche
Genentech
Bristol-Myers Squibb
Merck
HyperAcute Lung
HyperAcute Pancreas
Cancer Immunotherapy the Top Focus at ASCO
CNBC
Fri, 05/31/13 - 12:31 pm
ASCO
immunotherapy
cancer
Bristol-Myers Squibb
Roche
and Merck
ASCO presentations portend future shock of immunotherapy drug prices
Fierce Biotech
Thu, 05/30/13 - 11:37 am
ASCO
drug pricing
immunotherapy
Merck
Bristol-Myers Squibb
Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation'
Seeking Alpha
Wed, 05/22/13 - 09:35 am
Merck
immunotherapy
lambrolizumab
breakthrough therapies
Roche immunotherapy shows response over range of cancers
Reuters
Thu, 05/16/13 - 10:22 am
Roche
immunotherapy
MPDL3280A
melanoma
lung cancer
kidney cancer
Stocks Could Rise For Companies Investing In Immunotherapy Treatments
Seeking Alpha
Tue, 02/19/13 - 10:12 am
immunotherapy
Celgene
Bristol-Myers Squibb
OncoSec
ONYX Pharmaceuticals
Vical
Buying Teva's Immunotherapy Investment
Seeking Alpha
Thu, 12/6/12 - 11:18 am
Teva
immunotherapy
BIO 2012: Immunotherapies make a comeback at Big Pharma
Fierce Biotech
Mon, 06/25/12 - 11:24 am
immunotherapy
BIO Conference
FDA Seeks Data on Immunotherapy Drug
Mon, 04/16/12 - 10:22 pm
FDA
immunotherapy
data
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Seeking Alpha
Sun, 03/27/11 - 11:39 am
ipilimumab
monoclonal antibodies
immunotherapy
Yervoy
Bristol-Myers Squibb
melanoma
Bristol-Myers Squibb: PDUFA Date Looms for Ipilimumab
Seeking Alpha
Sat, 03/19/11 - 09:59 am
Bristol-Myers Squibb
PDUFA
ipilimumab
immunotherapy
Provenge
monoclonal antibodies
Merck cites positive study results on allergy drug
Yahoo/AP
Wed, 03/3/10 - 11:17 am
Merck
allergies
immunotherapy
Phleum Pratense

Pages